Top stock losers today: biggest decliners live
Top losers is the mirror of the gainers feed. It surfaces the names selling off hardest today, useful for short-side hunters, fade traders, and risk managers who need to see where their long book is bleeding.
Leader right now: NXL -29.40% at $5.33. Sourced from the live 15-min-delayed scanner snapshot above.
As of October 2, 2026 · delayed 15 min
What's moving the tape on NXL, grounded in Tapeboard's data. Not investment advice.
As of
- Nexalin Technology stock surged 80% on massive volume following a 10-year South American distribution and manufacturing deal. - Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, marking a major step in its transition toward commercial revenue generation.
- The company has secured a 10-year exclusive distribution agreement with Inovanexa Medical Technologies covering seven countries in South America. - Nexalin Technology has reported significant revenue growth, with a 78.8% increase in revenue year-over-year.
- The company has a net loss of $-0.01B and a negative EPS of $-0.5, indicating significant financial challenges. - The short interest is 0.0155% of float, which may indicate a lack of investor confidence in the stock.
- The company has a high debt-to-equity ratio, indicating potential financial risk. - The stock has a high volatility, with a 51.88% price change in the last day.
- The long-term impact of the 10-year exclusive distribution agreement is unclear. - The company's ability to generate commercial revenue and achieve profitability is uncertain. --- This is an automated summary of publicly available data, not financial advice. It is for informational purposes only — nothing here is a recommendation to buy or sell any security. Do your own research and consult a licensed financial advisor before making investment decisions.
What's moving the tape on WCT, grounded in Tapeboard's data. Not investment advice.
As of
- The stock price has dropped by 85.8% in the last trading session, with a price of $1.149. - The recent news headlines include "Wellchange Holdings Company Limited Announces 1-for-5 Reverse Stock Split Effective September 8, 2026" and "Wellchange Holdings Closes $7.5 Million Public Offering".
- The company has announced a reverse stock split, which may help to increase the stock price. - The company has also closed a $7.5 million public offering, which may provide additional funding for the company.
- The stock price has dropped significantly in the last trading session, which may indicate a decline in investor confidence. - The company's earnings have been disappointing, with a statutory profit gain from unusual items, which may not be repeated in the future.
- The company's short interest is low, with a squeeze score of 0 and a days to cover of 0.049. - The company's float is relatively small, with 591,462 shares available for trading.
- The company's future profitability is uncertain, with analysts forecasting a decline in earnings. - The company's ability to regain compliance with the minimum bid price requirement is also uncertain, with a deadline of April 27, 2026. --- This is an automated summary of publicly available data, not financial advice. It is for informational purposes only — nothing here is a recommendation to buy or sell any security. Do your own research and consult a licensed financial advisor before making investment decisions.
What's moving the tape on WDC, grounded in Tapeboard's data. Not investment advice.
As of
- Micron Slips 3% Despite Record Quarter and Above-Consensus Guidance; Western Digital Dips, SK Hynix ... — 24/7 Wall St. - SMCI or WDC: Which Is the Better Value Stock Right Now? — Zacks
--- This is an automated summary of publicly available data, not financial advice. It is for informational purposes only — nothing here is a recommendation to buy or sell any security. Do your own research and consult a licensed financial advisor before making investment decisions.
What's moving the tape on ALDX, grounded in Tapeboard's data. Not investment advice.
As of
- Aldeyra Therapeutics, Inc. (ALDX) plans to submit a Formal Dispute Resolution Request (FDRR) for reproxalap, an investigational drug candidate, for the treatment of dry eye disease. - The company received meeting minutes from the US Food and Drug Administration (FDA) and will hold a meeting with the FDA's Office of New Drugs (OND) in the fourth quarter of 2026.
- The company is taking steps to address the FDA's concerns and potentially gain approval for reproxalap. - Reproxalap has shown promise in clinical trials, with five of nine adequate and well-controlled clinical trials achieving all multiplicity-controlled primary endpoints.
- The FDA has already rejected reproxalap twice, and the company's FDRR may not be successful. - The company's financial situation is uncertain, with a net loss of $483.9 million in 2025 and a net debt of $547.9 million.
- The company's stock price has been volatile, with a 7% decline in the past day. - The company's short interest is 0.1% of float, which is relatively low.
- The outcome of the FDRR and the FDA's decision on reproxalap are uncertain. - The company's financial situation and potential for future funding are unknown. --- This is an automated summary of publicly available data, not financial advice. It is for informational purposes only — nothing here is a recommendation to buy or sell any security. Do your own research and consult a licensed financial advisor before making investment decisions.
See this live in the Tapeboard scanner
This table is baked at build time and never moves. The scanner runs the same scan continuously, streaming and filterable, with a chart and research pane one click away on every row. Free, no account needed.
Open the live top losers scannerWhat are the biggest loser movers today?
- Ranked by intraday percent decline, live refresh
- Default minimum daily volume floor at 500K shares
- Default minimum price filter at $1, configurable
- News-recency badge to flag downgrade or guidance-cut catalysts
- Click-through to a full chart, filings, and recent insider activity
- Streaming real-time. Rows update as prints land, not on a 10-second refresh delay.
- Click any ticker for the full research pane: chart, Level 2, time & sales, filings, insider activity, news recency.
- 15-minute delay on the public surface; signed-in users see the live tape without delay.
- Free to view. No card. No paywall on this page.
Other movers categories you might want next to this one:
Watch the movers live on Tapeboard.
28 sec to first scanner · no card · cancel anytime
Start free View pricing See it live in the scanner